Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Gross Profit | 860 | 1,110 | 970 | 1,830 | 2,490 |
| Operating Expenses | 5,780 | 4,570 | 4,280 | 4,010 | 4,820 |
| Operating Income | -5,780 | -4,570 | -4,280 | -4,010 | -4,820 |
| Pre-tax Income | -5,780 | -4,570 | -4,280 | -4,010 | -4,820 |
| Net Income Continuous | -5,780 | -4,570 | -4,280 | -4,010 | -4,820 |
| Net Income | $-5,780 | $-4,570 | $-4,280 | $-4,010 | $-4,820 |
| EBITDA(a) | $-4,700 | $-3,500 | $-3,320 | $-3,050 | $-3,850 |